(Q34366341)

1 August 2017

The spectrum of perinatal group B streptococcal disease (English)

1 reference

1 August 2017

Carol J Baker

1

1 reference

PubMed ID

23973344

1 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

1 August 2017

1 reference

1 August 2017

31 Suppl 4

1 reference

1 August 2017

D3-6

1 reference

A serological differentiation of human and other groups of hemolytic streptococci

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

FATAL INFECTIONS BY HqMOLYTIC STREPTOCOCCUS GROUP B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Suppurative meningitis due to streptococci of lancefield group B: A study of 33 infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Group B streptococcal infections in infants. The importance of the various serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Emergence and global dissemination of host-specific Streptococcus agalactiae clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Bacterial meningitis in the United States, 1998-2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Long-term outcomes of group B streptococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Variation in reported neonatal group B streptococcal disease incidence in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

Immunization to prevent group B streptococcal disease: victories and vexations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.030

10.1016/J.VACCINE.2013.02.030

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

23973344